IdentificationGeneric Name(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINEDrugBank Accession NumberDB07356BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE (DB07356)× CloseWeightAverage: 249.3519 Monoisotopic: 249.184112373 Chemical FormulaC14H23N3OSynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUDipeptidyl peptidase 4Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids.KingdomOrganic compoundsSuper ClassOrganic acids and derivativesClassCarboxylic acids and derivativesSub ClassAmino acids, peptides, and analoguesDirect ParentAlpha amino acid amidesAlternative ParentsN-acylpyrrolidines / Tertiary carboxylic acid amides / Azacyclic compounds / Acetylides / Organopnictogen compounds / Organic oxides / Monoalkylamines / Hydrocarbon derivatives / Carbonyl compoundsSubstituentsAcetylide / Aliphatic heteromonocyclic compound / Alpha-amino acid amide / Amine / Azacycle / Carbonyl group / Carboxamide group / Hydrocarbon derivative / N-acylpyrrolidine / Organic nitrogen compoundMolecular FrameworkAliphatic heteromonocyclic compoundsExternal Descriptorsterminal acetylenic compound, N-acylpyrrolidine (CHEBI:40697) Affected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyXYVMJMYCUZCIPB-AVGNSLFASA-NInChIInChI=1S/C14H23N3O/c1-2-11-7-8-12(9-15)17(11)14(18)13(16)10-5-3-4-6-10/h1,10-13H,3-9,15-16H2/t11-,12-,13-/m0/s1IUPAC Name(2S)-2-amino-1-[(2S,5R)-2-(aminomethyl)-5-ethynylpyrrolidin-1-yl]-2-cyclopentylethan-1-oneSMILES[H][C@](N)(C1CCCC1)C(=O)N1[C@]([H])(CN)CC[C@]1([H])C#CReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound11840917PubChem Substance99443827ChemSpider10015422ChEBI40697ZINCZINC000036470911PDBe LigandAIAPDB Entries2gbfClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.166 mg/mLALOGPSlogP0.46ALOGPSlogP0.33ChemaxonlogS-3.2ALOGPSpKa (Strongest Basic)9.26ChemaxonPhysiological Charge2ChemaxonHydrogen Acceptor Count3ChemaxonHydrogen Donor Count2ChemaxonPolar Surface Area72.35 Å2ChemaxonRotatable Bond Count3ChemaxonRefractivity70.92 m3·mol-1ChemaxonPolarizability28.33 Å3ChemaxonNumber of Rings2ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9339Blood Brain Barrier+0.9572Caco-2 permeable-0.6P-glycoprotein substrateNon-substrate0.583P-glycoprotein inhibitor INon-inhibitor0.81P-glycoprotein inhibitor IINon-inhibitor0.6633Renal organic cation transporterNon-inhibitor0.679CYP450 2C9 substrateNon-substrate0.8943CYP450 2D6 substrateNon-substrate0.644CYP450 3A4 substrateNon-substrate0.6612CYP450 1A2 substrateNon-inhibitor0.8023CYP450 2C9 inhibitorNon-inhibitor0.8423CYP450 2D6 inhibitorNon-inhibitor0.883CYP450 2C19 inhibitorNon-inhibitor0.7431CYP450 3A4 inhibitorNon-inhibitor0.8404CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.7212Ames testNon AMES toxic0.7636CarcinogenicityNon-carcinogens0.9091BiodegradationNot ready biodegradable0.9274Rat acute toxicity2.1588 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9496hERG inhibition (predictor II)Non-inhibitor0.809  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Dipeptidyl peptidase 4KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionVirus receptor activitySpecific FunctionCell surface glycoprotein receptor involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation. Acts as a positive regulator of T-cell coactivation, by bindi...Gene NameDPP4Uniprot IDP27487Uniprot NameDipeptidyl peptidase 4Molecular Weight88277.935 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:20 / Updated at June 12, 2020 16:52 